Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.
The AES Corporation received unconditional merger approval from the European Commission and a favorable declaratory ruling from the New York Public Service Commission regarding its pending acquisition by Horizon Parent, L.P. The transaction, originally announced in March 2026, will result in AES being jointly owned by Global Infrastructure Management, LLC and EQT Infrastructure VI. The deal remains subject to additional regulatory approvals and customary closing conditions.
VenHub Global announced that its existing Equity Line of Credit (ELOC) has been assigned from Euphoria Capital to Tunim Stone Capital, LLC. Under the Assignment and Assumption Agreement, Tunim Stone Capital assumes all rights and obligations of the ELOC, while Euphoria Capital retains 500,000 commitment shares and associated registration rights.
Vivos Therapeutics Signs $12M M&A Deal with SOD Sciences, Inc.
Vivos Therapeutics completed the acquisition of an 11% equity stake in SOD Sciences and a 50% co-ownership interest in SOD's pseudohypoxia early-warning test. The transaction was valued at $12 million, paid via the issuance of 12,000 shares of Series C Convertible Preferred Stock, and is expected to add over $10 million to Vivos' stockholders' equity.
Value
$12M
Counterparty
SOD Sciences, Inc.
“Today Vivos became more than a healthcare company just treating sleep apnea. We expect this transaction to add more than $10 million to our stockholders’ equity, and we now own half of a test designed to identify patients whose sleep apnea may be contributing to chronic disease.”
R. Kirk Huntsman, Chairman and Chief Executive Officer of Vivos
Service Properties Trust (SVC) completed the sale of three hotels for an aggregate sales price of $19.0 million on October 15, 2026. The transaction was executed pursuant to a previously entered purchase and sale agreement and was reported as a significant disposition of assets.
Eva Live Inc. filed a prospectus supplement to facilitate an existing equity purchase agreement with Hudson Global Ventures, LLC. The agreement allows the company to sell up to 5,000,000 shares of common stock for an aggregate price of up to $10 million. Additionally, the company issued a warrant to the investor for 275,000 shares at an exercise price of $0.01 per share.
Curis, Inc. entered into a securities purchase agreement to raise approximately $8.5 million through the sale of 16,666,680 shares of common stock (or pre-funded warrants) and accompanying common warrants at a combined price of $0.51 per share. The company intends to use the proceeds to fund research and development activities, specifically to support operations through its initial Chronic Lymphocytic Leukemia (CLL) data readout expected in December 2026.
Medtronic plc has completed the separation of its diabetes business, MiniMed Group, Inc., into an independent publicly traded company via a tax-free exchange offer. Medtronic exchanged its remaining 252,813,348 shares of MiniMed common stock for outstanding Medtronic ordinary shares in an offer that was 5.4x oversubscribed.
Curaleaf Holdings M&A Deal with Aurora Cannabis Inc.
Curaleaf Holdings, Inc. responded to Aurora Cannabis Inc.'s rejection of its enhanced acquisition proposal, challenging the Aurora Board's refusal to grant due diligence access. Curaleaf noted its offer represents an 86% premium to Aurora's unaffected 30-day VWAP and criticized Aurora for providing diligence access to other unnamed parties while obstructing Curaleaf's binding offer.
Cambium Networks Divestiture to Univastu UK Limited for $5.1M
Cambium Networks' subsidiary, Cambium Networks, Ltd (in administration), completed the sale of its remaining business and assets to Univastu UK Limited for approximately $5.1 million. The transaction includes the 'Cambium' brand name, intellectual property, and all shares in group subsidiaries across multiple countries, effectively disposing of the company's remaining product lines as a going concern.
Construction Partners M&A Deal with S.E. Cline Construction, Inc.
Construction Partners, Inc. (CPI) has completed the acquisition of S.E. Cline Construction, Inc., a commercial site development and underground utility construction company based in Palm Coast, Florida. The deal includes approximately 60 employees and a rail-served, permitted hot-mix asphalt plant site in Bunnell, Florida, which will be integrated into CPI's Florida platform, C.W. Roberts Contracting. This acquisition expands CPI's operations along the growing Interstate 95 corridor in northeast and central Florida.
SpyGlass Pharma announced positive 4-year interim results from its first-in-human trial of the BIM-IOL System for glaucoma patients undergoing cataract surgery. The data showed a 37% reduction in mean intraocular pressure and 86% of patients remained off topical drops with no product-related adverse events reported.
CCO Holdings Capital M&A Deal with Cox Communications, Inc.
Charter Communications provided a status update regarding its completed transactions with Cox Communications. The company has posted a revised trending schedule to its investor relations website containing pro forma financial and operating information as if the deal had closed on January 1, 2024.
ACV Auctions Inc. has completed its merger with Copart, Inc., becoming a wholly owned subsidiary of Copart. The transaction was executed via a tender offer for all outstanding shares of ACV Stock at $10.50 per share, followed by a second-step merger under Section 251(h) of the DGCL.
Non Invasive Monitoring Systems M&A Deal with Gravitics, Inc.
Non-Invasive Monitoring Systems entered into a fourth amendment to its merger agreement with Gravitics, Inc. The amendment modifies the definition of the required 'Public Offering' to gross proceeds expected to be $50 million, with a minimum threshold of $40 million. All other terms of the previously announced merger remain unchanged.
Stonepeak-Plus Infrastructure Fund Capital Raise of $38.8M
Stonepeak-Plus Infrastructure Fund LP sold unregistered limited partnership units to third-party investors for approximately $38.77 million on October 1, 2026. The sale was part of a continuous private offering, with the fund and its affiliated vehicle raising a total of approximately $1.99 billion since inception in May 2025.
PLAYSTUDIOS, Inc. has regained compliance with Nasdaq's $1.00 minimum bid price requirement for continued listing on The Nasdaq Capital Market. The company achieved this by maintaining a closing bid price at or above $1.00 for ten consecutive business days following a 1-for-10 reverse stock split effected on September 30, 2026.
Cottonwood Communities, Inc. raised approximately $2.08 million through the sale of 210,135 shares of its Series 2025 Preferred Stock in a private placement offering. The shares were sold to accredited investors at a purchase price of $10.00 per share between September 22 and October 18, 2026. This activity is part of an ongoing private offering launched in December 2024 with a maximum target of $150 million.
Adia Med, Inc. entered into a Membership Interest Purchase Agreement to sell a 7% membership interest in its subsidiary, Adia Labs LLC, to the company's CEO, Larry A. Powalisz. The transaction is valued at $350,000 in cash, with the use of proceeds restricted to corporate purposes jointly approved by the company's independent directors.
Ford Credit Floorplan Master Owner Trust a Capital Raise
Ford Credit Floorplan Master Owner Trust A entered into definitive transaction documents, including an Indenture Supplement and Account Control Agreement, for the issuance of Series 2026-3 asset-backed notes. The filing formalizes the legal structure for the trust's latest issuance of securities backed by dealer floorplan receivables.
Barrel Energy Signs $20M M&A Deal with Maine Bio-Fuel, Inc.
Barrel Energy Inc. has signed a letter of intent to acquire a 51% controlling interest in Maine Bio-Fuel, Inc. (doing business as Maine Standard Biofuels) for $20 million in cash and stock. The closing is contingent upon Barrel completing a separate business combination with a company listed on a national exchange (Nasdaq or NYSE) and securing a qualifying credit facility to fund the cash portion of the deal.
Tcgx Acquisition Signs $361M M&A Deal with TriGemX Bio, Inc.
TCGX Acquisition Corp. (SPAC) has entered into a definitive business combination agreement with TriGemX Bio, Inc. at a pre-money equity value of $361 million. The transaction includes a concurrent $160 million PIPE financing and is expected to provide approximately $246 million in gross proceeds to fund Phase 3 development of elismetrep for migraine. Upon closing, expected in Q1 2027, the combined company will be named TriGemX Bio, Inc. and trade on Nasdaq under the ticker TGEM.
Veradermics announced positive topline results from its Phase 3 '304' clinical trial of VDPHL01 for male pattern hair loss, meeting all primary and secondary endpoints with high statistical significance. The study demonstrated robust increases in hair count and rapid onset of activity as early as Month 2, with a favorable safety profile and no treatment-related serious adverse events. These results, combined with prior Phase 2/3 data, support a potential FDA submission for the first non-hormonal oral treatment for pattern hair loss.
Data I Signs $13.2M M&A Deal with V-TEK and A&J Programming
Data I/O Corporation has entered into a definitive agreement to acquire V-TEK and A&J Programming. To fund the transaction and provide working capital, the company also announced a $13.25 million private placement of convertible subordinated debentures and common shares at a conversion price of $2.68 per share.
Cardinal Infrastructure Group Signs $358M M&A Deal with Hughes Brothers Construction Inc.
Cardinal Infrastructure Group entered into a definitive agreement to acquire Hughes Brothers Construction Inc., a Central Florida heavy civil and site development contractor, for an aggregate purchase price of $357.5 million. The consideration consists of $214.5 million in cash and $143.0 million in Class A common stock, with an additional earn-out potential of up to $162.5 million based on future EBITDA performance. The acquisition establishes a scaled platform for Cardinal in the fast-growing Florida market and is expected to close in the fourth quarter of 2026.
Value
$358M
Counterparty
Hughes Brothers Construction Inc.
“We are excited to welcome Hughes Brothers to Cardinal as we take another important step in our strategy to build the Southeast’s premier site development platform by moving into the fast-growing Central Florida market. Hughes Brothers is an exceptional founder-led business that culturally aligns with what we’re building. They bring an experienced team, both in terms of field personnel and corporate leadership, longstanding customer relationships, h”
Jeremy Spivey, CEO of Cardinal Infrastructure Group
OS Therapies announced the initial closing of a warrant exercise inducement and exchange offer, raising $7.2 million in gross proceeds from seven accredited investors. Participating holders exercised warrants at a reduced price of $1.30 per share in exchange for new warrants to purchase an equal number of shares at $1.40. The proceeds will fund regulatory filings and commercial preparation for Herlystic™ in the U.S., U.K., EU, and Australia.
Dogwood Therapeutics entered into a subscription agreement to sell 4,098,360 shares of common stock to its largest shareholder, Sealbond Limited (a subsidiary of CK Life Sciences), in a $5 million private placement. The proceeds will be used to fund Phase 3 preparatory activities for Halneuron® and extend the company's operational runway through March 2027.
Atkore Inc. completed its merger with Prysmian S.p.A., with Atkore becoming a wholly owned subsidiary of Prysmian. Shareholders of Atkore received $95.00 in cash per share. In connection with the closing, Atkore terminated its existing credit facilities and redeemed $400 million of its 4.25% Senior Notes due 2031.
Fuller H B Signs $1.4B M&A Deal with Ancora Holdings Group LLC
H.B. Fuller's Board of Directors unanimously rejected a second unsolicited, non-binding proposal from Ancora Holdings Group LLC to acquire the Company's Building Adhesive Solutions (BAS) business for $1.2 billion to $1.4 billion. The Board determined the offer undervalued the segment and lacked sufficient detail, though the Company will conduct a market check for select market segments and product lines by year-end 2026 to evaluate potential divestitures for deleveraging.
Mks Divestiture to TTM Technologies, Inc. for $650M
MKS Inc. has entered into a definitive agreement to sell its Ophir Optics business to TTM Technologies, Inc. for $650 million in cash. The transaction, which represents an 18x multiple of projected 2026 Adjusted EBITDA, is expected to close in the second quarter of 2027 and aims to strengthen MKS's balance sheet while focusing on its core semiconductor and electronics markets.
Ttm Technologies Signs $650M M&A Deal with MKS Inc.
TTM Technologies has entered into a definitive agreement to acquire the Ophir Optics business from MKS Inc. for approximately $650 million in an all-cash transaction. The acquisition adds high-precision infrared thermal imaging and laser optics capabilities to TTM's defense and industrial portfolio and is expected to close in the second quarter of 2027.
Value
$650M
Counterparty
MKS Inc.
“We are excited to announce our planned acquisition of the Ophir Optics business as another important step toward enhancing our long-term growth strategy by expanding our portfolio with mission-critical optical solutions for land, air, maritime, and unmanned platforms and our industrial portfolio.”